Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya (myPlanKenya)

July 29, 2026 updated by: Johns Hopkins Bloomberg School of Public Health

This effectiveness-implementation hybrid-3 study evaluates dissemination, implementation, and effectiveness of myPlanKenya. myPlanKenya will be disseminated through formal and informal sectors. This clinical trial portion of the study enrolls women at risk for intimate partner violence (IPV) who are referred to myPlanKenya by disseminators (i.e. "end-users").

This trial aims to evaluate the effectiveness of myPlanKenya referral on resilience, health and safety among a cohort of women referred to myPlanKenya based on disclosure of IPV or assessed to have IPV related risks.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

440

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Kenya
      • Nairobi, Kenya
        • Ujamaa Africa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female
  • Age 16 or older
  • Physical or sexual partner violence or relationship-based fears within the past six months; behaviorally assessed
  • Living in Nairobi, Kenya with no plans to move in the next 12 months
  • Access to a safe smart phone or computer (personal or shared), and comfort using it to access the myPlan Kenya app
  • Literate in English or Swahili languages; confirmed by reading and completing a short passage by filling in several blanks with the appropriate words, selected from a drop-down menu.

Exclusion Criteria:

  • Male
  • Under age 16
  • Have not experienced physical or sexual partner violence or relationship-based fears in past 6 months
  • Lives outside of the study area or plans to move within the next 12 months
  • Does not have access to a safe smart phone or computer, or is uncomfortable using it to access the myPlan Kenya app
  • Illiterate in English or Swahili languages

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: myPlan Kenya
myPlan Kenya web-based application
Behavioral: Personalized safety planning tool
The myPlan Kenya app is a web-based safety planning tool that is secure, private, free and personalized to the user. The app includes multiple, evidence-based modules: Strategies (safety strategies tailored to the user's needs and violence experience); Resources (referrals to local health, safety and justice resources and services); About You (questionnaires that help the user assess their relationship safety and tailor their Strategies, including My Relationship, Red Flags, My Safety, My Priorities); Understanding (knowledge sections that share information on relationships and violence, including Healthy Relationships, Harmful Beliefs About Abuse, About Violence).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resilience as Assessed by Connor-Davidson Resilience Scale
Time Frame: Baseline, 6-month, 12-month
10-item Connor-Davidson Resilience Scale assesses resilience using a 5-point Likert scale (0-4). Scored from 0-40, with higher scores indicating greater resilience and lower scores indicating lower resilience.
Baseline, 6-month, 12-month
Decisional Conflict Score
Time Frame: Baseline, 6-month, 12-month
12-item decisional conflict measures (specific to safety), assessed using a 5-point Likert scale (0-4). The mean Decisional Conflict score is multiplied by 25 to create an overall score, ranging from 0-100; 0 (no decisional conflict) to 100 (extremely high decisional conflict).
Baseline, 6-month, 12-month
Safety/IPV Experience(s) as Assessed by the Conflict Tactics Scale-2
Time Frame: Baseline, 6-month, 12-month
10-item adapted Conflict Tactics Scale-2 (CTS2), which assesses IPV experiences using a 3-point scale on the frequency of these experiences. Score range 0-20; higher score indicates more IPV.
Baseline, 6-month, 12-month
Percentage of Participants Who Sought Services (Help-seeking)
Time Frame: Baseline, 6-month, 12-month
6-item index on help-seeking, which assesses abuse disclosure and services/information received on a 2-point scale (yes/no); operationally defined as percentage of participants who sought help from any of the services.
Baseline, 6-month, 12-month
Helpfulness of Services Assessed by Help-Seeking Index
Time Frame: Baseline, 6-month, 12-month
6-item index on help-seeking which assesses abuse disclosure and services/information. Helpfulness of services rated on a 5-point Likert scale (Score range 0-4; with higher score more helpful). Mean helpfulness score of services sought is reported.
Baseline, 6-month, 12-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Safety Strategy Score
Time Frame: Baseline, 6-month, 12-month
5-item index on safety strategies used (yes/no), summed for a range of 0-5 with higher scores indicating more safety strategies used. For each strategy used, helpfulness is assessed on a 5-point Likert scale (1-5), with higher scores indicating more helpfulness; mean scores are presented (range 1-5).
Baseline, 6-month, 12-month
IPV Recognition as Assessed by the Abusive Behaviors Scale
Time Frame: Baseline, 6-month, 12-month
7-item adapted Abusive Behaviors Scale, which assesses IPV recognition using a 5-point Likert scale (0-4). Items are scored from 0-28, with higher scores indicating greater IPV recognition and lower scores indicating lower IPV recognition.
Baseline, 6-month, 12-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Ujamaa Africa

Investigators

  • Principal Investigator: Michele Decker, Johns Hopkins Bloomberg School of Public Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2022

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

April 19, 2025

Study Registration Dates

First Submitted

November 2, 2022

First Submitted That Met QC Criteria

November 2, 2022

First Posted (Actual)

November 8, 2022

Study Record Updates

Last Update Posted (Actual)

July 31, 2026

Last Update Submitted That Met QC Criteria

July 29, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB00017456
  • R01HD099144 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe